Phase I Study of SYS6043 in Patients With Advanced/Metastatic Solid Tumors
Conjupro Biotherapeutics, Inc.
Conjupro Biotherapeutics, Inc.
Ensem Therapeutics
QuantumLeap Healthcare Collaborative
Eisai Inc.
Institut du Cancer de Montpellier - Val d'Aurelle
Clinica Universidad de Navarra, Universidad de Navarra
Alterome Therapeutics, Inc.
National Institutes of Health Clinical Center (CC)
UMC Utrecht
George Washington University
Psyence Australia Pty Ltd
Eli Lilly and Company
ViroMissile, Inc.
Institut Curie
University of Florida
University of Missouri-Columbia
Tizona Therapeutics, Inc
Essen Biotech
Essen Biotech
Centre Leon Berard
A2 Biotherapeutics Inc.
AstraZeneca
Angiex, Inc.
Case Comprehensive Cancer Center
Stemline Therapeutics, Inc.
UNC Lineberger Comprehensive Cancer Center
Allegheny Singer Research Institute (also known as Allegheny Health Network Research Institute)
Cancer Research Antwerp
Allegheny Singer Research Institute (also known as Allegheny Health Network Research Institute)
Iambic Therapeutics, Inc
Allegheny Singer Research Institute (also known as Allegheny Health Network Research Institute)
Centre Hospitalier de Valenciennes
DualityBio Inc.
EXoPERT
Colorado State University
University of Alberta
EXoPERT
Elephas
BriaCell Therapeutics Corporation
Var2 Pharmaceuticals
OncoNano Medicine, Inc.
GlaxoSmithKline
AC Camargo Cancer Center
Baptist Health South Florida
Rondo Therapeutics
UNC Lineberger Comprehensive Cancer Center
UNC Lineberger Comprehensive Cancer Center
University of Calgary
Institut Bergonié
National University Hospital, Singapore